Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUCNR1 | Q9BXA5 | 9/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | C3AR1 | Q16581 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26263209 | 0.89 | SUCNR1 (0.61) | SUCNR1ALDH1A1HPGDC3AR1 | |
| SCHEMBL26263232 | 0.88 | SUCNR1 (0.61) | SUCNR1C3AR1 | |
| SCHEMBL26263219 | 0.88 | SUCNR1 (0.61) | SUCNR1ALDH1A1KDM4EHPGDC3AR1 | |
| SCHEMBL26264257 | 0.87 | SUCNR1 (0.69) | SUCNR1ALDH1A1KDM4ELMNAHPGD | |
| SCHEMBL26263245 | 0.86 | SUCNR1 (0.56) | SUCNR1KDM4E | |
| SCHEMBL26263243 | 0.86 | SUCNR1 (0.68) | SUCNR1ALDH1A1C3AR1MEN1MGAM | |
| SCHEMBL26263246 | 0.84 | SUCNR1 (0.59) | SUCNR1C3AR1 | |
| SCHEMBL26263253 | 0.84 | SUCNR1 (0.83) | SUCNR1C3AR1NPC1 | |
| SCHEMBL26263250 | 0.83 | SUCNR1 (0.62) | SUCNR1KDM4EMAPT | |
| SCHEMBL26263255 | 0.83 | SUCNR1 (0.64) | SUCNR1C3AR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293504-A1 | TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION | UNIV NEW YORK (US) | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293504-A1 | TARGETING SUCNR1 TO REDUCE NEUROINFLAMMATION | SUCNR1, SYNGR2, TSPO | SUCNR1 1/4885ALDH1A1 1666/4885KDM4E 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.